Healthcare ❯ Cancer Treatment
Clinical Trials Patient Support mRNA Technology mRNA-based Therapies T-cell Engineering Immune Checkpoint Inhibitors Vaccine Development Advanced Melanoma
The review moves RP1 plus nivolumab into formal evaluation after a June rejection.
